Skip to Main Content

Paper Details

Multi-omics analysis of mucosal and systemic immunity to SARS-CoV-2 after birth.
Cell
6
2023
CXCL1, IFN, IL-8, ISGs, Infants, Omicron, SARS, SARS-CoV, SARS-CoV-2, children, infants, innate cells, interferon, interferon-stimulated genes, myeloid cells, severe, severe acute respiratory syndrome coronavirus
Author NameAffiliation
Florian WimmersInterfaculty Institute for Biochemistry, University of Tuebingen, German Cancer Research Center (DKFZ)
Yupeng FengInstitute for Immunity, Stanford University
Prabhu S ArunachalamInstitute for Immunity, Stanford University
Thomas HaganCincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine
Alessandro SetteCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), University of California
Alessandro SetteCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), University of California
Steven E BosingerYerkes National Primate Research Center, Emory University School of Medicine
Holden T MaeckerInstitute for Immunity, Stanford University, Stanford University School of Medicine
Paul J UtzInstitute for Immunity, Stanford University, Stanford University School of Medicine
Bali PulendranInstitute for Immunity, Stanford University, Stanford University School of Medicine
Bali PulendranInstitute for Immunity, Stanford University, Stanford University School of Medicine
  • 1 - 11

Datasets